Therefore, in the current post-hoc analysis of the previously reported FEATHER study, we investigated whether baseline TNFR levels and early change in circulating TNFR levels predicted 30% eGFR decline chiefly in non-diabetic CKD patients with asymptomatic hyperuricemia. The gene discussed is TNFRSF1A; the disease is hyperuricemia.